0000874716-23-000145.txt : 20231208 0000874716-23-000145.hdr.sgml : 20231208 20231208170021 ACCESSION NUMBER: 0000874716-23-000145 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231207 FILED AS OF DATE: 20231208 DATE AS OF CHANGE: 20231208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: POLEWACZYK JAMES F CENTRAL INDEX KEY: 0001389046 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 231476203 MAIL ADDRESS: STREET 1: IDEXX LABORATORIES, INC. STREET 2: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 wk-form4_1702072812.xml FORM 4 X0508 4 2023-12-07 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001389046 POLEWACZYK JAMES F ONE IDEXX DRIVE WESTBROOK ME 04092 0 1 0 0 Executive Vice President 0 Common Stock 2023-12-07 4 M 0 4956 206.94 A 15005.9875 D Common Stock 2023-12-07 4 M 0 6680 288.78 A 21685.9875 D Common Stock 2023-12-07 4 S 0 3116 520.1922 D 18569.9875 D Common Stock 2023-12-07 4 S 0 3378 521.0046 D 15191.9875 D Common Stock 2023-12-07 4 S 0 1202 522.3094 D 13989.9875 D Common Stock 2023-12-07 4 S 0 3940 523.5563 D 10049.9875 D Non-Qualified Stock Option (right-to-buy) 206.94 2023-12-07 4 M 0 4956 0 D 2029-02-13 Common Stock 4956 755 D Non-Qualified Stock Option (right-to-buy) 288.78 2023-12-07 4 M 0 6680 0 D 2030-02-13 Common Stock 6680 2226 D Includes 12 shares purchased under the Issuer's Employee Stock Purchase Plan on September 29, 2023. Represents the weighted average price of the shares sold ranging from a low of $519.73 to a high of $520.73 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $520.74 to a high of $521.235 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $521.99 to a high of $522.935 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $523.05 to a high of $523.885 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Grant of option to buy 5,711 shares of Issuer common stock that vest in five annual installments beginning February 14, 2020. Grant of option to buy 8,906 shares of Issuer common stock that vest in four annual installments beginning February 14, 2021. /s/ Lily J. Lu, Attorney-in-Fact for James F. Polewaczyk 2023-12-08